Last reviewed · How we verify

NCT03161067: BiCNS

Investigation on the Bidirectional Cortical Neuroprosthetic System

Recruiting now NA Last updated 9 September 2025
What this trial tests

NA trial testing BiCNS in Tetraplegia in 5 participants. Currently enrolling.

Timeline
1 August 2017
Primary endpoint
31 July 2026
30 September 2027

Quick facts

Lead sponsorJohns Hopkins University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment5
Start date1 August 2017
Primary completion31 July 2026
Estimated completion30 September 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Johns Hopkins University

Who can join

Adults 22 to 65, any sex, with Tetraplegia or Quadriplegia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Bidirectional Cortical Neuroprosthetic System (BiCNS) consists of NeuroPort Microelectrode Array Systems and NeuroPort Electrodes (Sputtered Iridium Oxide Film), Patient Pedestals, the NeuroPort BioPotential Signal Processing System, and the CereStim C96 Programmable Stimulator. The goals of this early feasibility study consist of safety and efficacy evaluations of this device.

Publications & conference data

6 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Intracortical Somatosensory Stimulation to Elicit Fingertip Sensations in an Individual With Spinal Cord Injury.
    Fifer MS, McMullen DP, Osborn LE, Thomas TM, et al · · 2022 · cited 67× · PMID 34880087 · DOI 10.1212/wnl.0000000000013173
  2. Shared Control of Bimanual Robotic Limbs With a Brain-Machine Interface for Self-Feeding.
    Handelman DA, Osborn LE, Thomas TM, Badger AR, et al · · 2022 · cited 28× · PMID 35837250 · DOI 10.3389/fnbot.2022.918001
  3. Use of Invasive Brain-Computer Interfaces in Pediatric Neurosurgery: Technical and Ethical Considerations.
    Bergeron D, Iorio-Morin C, Bonizzato M, Lajoie G, et al · · 2023 · cited 26× · PMID 37116888 · DOI 10.1177/08830738231167736
  4. Quantifying physical degradation alongside recording and stimulation performance of 980 intracortical microelectrodes chronically implanted in three humans for 956-2130 days.
    Bjånes DA, Kellis S, Nickl R, Baker B, et al · · 2025 · cited 12× · PMID 40037510 · DOI 10.1016/j.actbio.2025.02.030
  5. Subthreshold intracortical microstimulation of human somatosensory cortex enhances tactile sensitivity.
    Osborn LE, Christie B, McMullen DP, Arriola V, et al · · 2025 · cited 1× · PMID 40216307 · DOI 10.1016/j.brs.2025.03.021
  6. Characteristics and stability of sensorimotor activity driven by isolated-muscle group activation in a human with tetraplegia.
    Nickl RW, Anaya MA, Thomas TM, Fifer MS, et al · · 2022 · cited 1× · PMID 35725741 · DOI 10.1038/s41598-022-13436-2

Verify or expand the search:

Other recruiting trials for Tetraplegia

Currently open trials in the same condition.

Other Johns Hopkins University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03161067.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing